Aktiviere Job-Benachrichtigungen per E-Mail!
Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf
Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren
The LIT – Leibniz Institute for Immunotherapy is seeking a Computational Scientist/Bioinformatician to join their international team in Germany. This role focuses on bioinformatic analyses of T-cell responses, offering an exciting opportunity for professionals with a strong background in bioinformatics and a passion for cancer research.
Organisation/Company Academic Europe Research Field Medical sciences » Cancer research Biological sciences » Biology Medical sciences » Other Other Researcher Profile Recognised Researcher (R2) Positions Postdoc Positions Country Germany Application Deadline 27 Jul 2025 - 23:59 (Europe/Berlin) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Other EU programme Is the Job related to staff position within a Research Infrastructure? No
The LIT – Leibniz Institute for Immunotherapy (foundation under civil law) (www.lit.eu ) – is a biomedical research center focusing on translational immunology in the fields of cancer immunotherapy, transplant rejection and autoimmunity. The objective of the LIT is to develop innovative and efficient cellular immune therapeutics in these areas. Our own GMP laboratories and close networking with University and University Hospital offer excellent opportunities for clinical translation of novel immune cell products.
The Division of Tailored T-cell diversity is recruiting a highly motivated
Computational Scientist/ Bioinformatician
(full time 40.1 hours per week)
The position is initially limited to two years with the possibility of further employment.
The position is within an international team that investigates the diversity within T cell responses to cancer, infections and inflammatory diseases. Our lab combines advanced flow cytometry, single-cell omics, computational approaches, functional assays, in vitro work, in vivo studies in mice and analyses on human samples to study the diversification of T cells (Zwijnenburg et al., Immunity 2023, PMID: 37490909 | Pokharel & Shryki at al. Eur J Immunol 2024, PMID: 37816219). Understanding how and when T cells diversify to adopt different roles paves the way for influencing T cell fates in the context of immunotherapy. In this position, you will drive the bioinformatical/computational aspects of collaborative projects aiming to ultimately improve immunomonitoring of cancer patients by providing a refined strategy to interpret T cell states.
Your tasks include, but are not limited to:
The ideal candidate possesses:
We offer:
The remuneration is based on TV-L. The Leibniz Institute for Immunotherapy aims to increase the share of women in the workforce. Therefore, qualified female candidates are explicitly encouraged to submit their applications. Moreover, the LIT advocates for the compatibility of family and career.
Disabled applicants (m/f/d) with equal qualifications will receive preferential treatment within the recruitment procedure. Please refer to your disability status already in your application.
Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.
For more information, please contact Prof. Dr. Carmen Gerlach (Carmen.Gerlach@lit.eu ). We are looking forward to receiving your detailed application. Please apply via our Online – Application Portal the reference CG-2025-02. Application deadline is July 27th, 2025.
Number of offers available 1 Company/Institute LIT – Leibniz Institute for Immunotherapy Country Germany City Regensburg Geofield